www.neuroendocrinecancer.org.uk
What is Radioligand Therapy?
Radioligand therapy (RLT) is a treatment that can be used to target certain types of neuroendocrine cancer. It is a targeted form of nuclear medicine that uses radiation to destroy cancer cells while minimising damage to healthy cells.
RLT is also known as Molecular Radiotherapy (MRT) or Peptide Receptor Radionuclide Therapy (PRRT), or by the specific radioligand used.
RLT uses radioactive drugs (radiopharmaceuticals) to directly target neuroendocrine cancer cells, particularly neuroendocrine tumours (NETs).
Made with FlippingBook Annual report maker